Literature DB >> 6472484

MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

J R Fozard.   

Abstract

The properties of MDL 72222 (1 alpha H, 3 alpha, 5 alpha H-tropan-3-yl-3,5-dichlorobenzoate), a novel compound with potent and selective blocking actions at certain excitatory 5-hydroxytryptamine (5-HT) receptors on mammalian peripheral neurones, are described. On the rabbit isolated heart, MDL 72222 was a potent antagonist of responses mediated through the receptors for 5-HT present on the terminal sympathetic fibres. The threshold for antagonism was approximately 0.1 nM and the negative logarithm of the molar concentration of MDL 72222 which reduced the chronotropic response of the isolated rabbit heart to twice an ED50 of 5-HT to that of the ED50 was 9.27. MDL 72222 was also highly selective since responses to the nicotine receptor agonist, dimethylphenylpiperazinum iodine (DMPP), were inhibited only at concentrations more than 1000 times those necessary to inhibit 5-HT. In the anaesthetised rat, MDL 72222 produced marked blockade of the Bezold-Jarisch effect of 5-HT. Again, inhibition was selective since much higher doses of MDL 72222 failed to alter the response to electrical stimulation of the efferent vagus nerves. In contrast, MDL 72222 proved only a weak and essentially non-selective antagonist of responses mediated by the 5-HT M-receptor present on the cholinergic nerves of the guinea-pig ileum. MDL 72222 does not block smooth muscle contractile responses elicited by oxytocin or mediated through 5-HT D-receptors, muscarinic or nicotinic cholinoceptors or histamine H1-receptors except at relatively high concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6472484     DOI: 10.1007/BF00518776

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  The history of the Bezold-Jarisch effect.

Authors:  O KRAYER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1961

2.  Cardiovascular and respiratory response to intravenous serotonin in rats.

Authors:  J W MCCUBBIN; I H PAGE; G C SALMOIRAGHI
Journal:  J Pharmacol Exp Ther       Date:  1956-12       Impact factor: 4.030

3.  The hypotensive action of 5-hydroxytryptamine (5-HT) in anaesthetised and pithed rats.

Authors:  J R Fozard; G D Leach
Journal:  Eur J Pharmacol       Date:  1968-02       Impact factor: 4.432

4.  Muscarinic postsynaptic events in the cat superior cervical ganglion in situ.

Authors:  W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  A useful muscarinic parameter and the differential recording of atrial and ventricular tension in the perfused rabbit heart.

Authors:  J R Fozard; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

6.  Blockade of neuronal tryptamine receptors by metoclopramide.

Authors:  J R Fozard; A T Mobarok ALI
Journal:  Eur J Pharmacol       Date:  1978-05-01       Impact factor: 4.432

7.  Mechanism of the indirect sympathomimetic effect of 5-hydroxytrypt-amine on the isolated heart of the rabbit.

Authors:  J R Fozard; G M Mwaluko
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

8.  Blockade of serotonin receptors on autonomic neurones by (-)-cocaine and some related compounds.

Authors:  J R Fozard; A T Mobarok Ali; G Newgrosh
Journal:  Eur J Pharmacol       Date:  1979-11-16       Impact factor: 4.432

9.  Two kinds of tryptamine receptor.

Authors:  J H GADDUM; Z P PICARELLI
Journal:  Br J Pharmacol Chemother       Date:  1957-09

10.  MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

Authors:  J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

View more
  102 in total

1.  Pharmacological characterization of the 5-HT receptor-mediated contraction in the mouse isolated ileum.

Authors:  B R Tuladhar; M D Womack; R J Naylor
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract.

Authors:  S Champaneria; B Costall; R J Naylor; D W Robertson
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

Review 3.  5-HT3 receptor antagonists and migraine therapy.

Authors:  M D Ferrari
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

4.  Activation of submucosal 5-HT(3) receptors elicits a somatostatin-dependent inhibition of ion secretion in rat colon.

Authors:  N Yang; S M Liu; L F Zheng; T Ji; Y Li; X L Mi; H Xue; W Ren; J D Xu; X H Zhang; L S Li; Y Zhang; J X Zhu
Journal:  Br J Pharmacol       Date:  2010-03-05       Impact factor: 8.739

5.  Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors.

Authors:  A Hamik; S J Peroutka
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Serotonin involvement in the discriminative stimulus effects of kappa opioids in pigeons.

Authors:  M E Bronson; Y P Lin; K Burchett; M J Picker; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT3 receptor-mediated von Bezold-Jarisch reflex.

Authors:  Grzegorz Godlewski; Manfred Göthert; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

8.  Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS.

Authors:  T J Feuerstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

9.  Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of "5-hydroxytryptamine1-like" receptors.

Authors:  P R Saxena; D J Duncker; A H Bom; J Heiligers; P D Verdouw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

10.  Characterization of 5-HT3 receptors of N1E-115 neuroblastoma cells by use of the influx of the organic cation [14C]-guanidinium.

Authors:  H Bönisch; M Barann; J Graupner; M Göthert
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.